Prognostic Implications of Degenerative Mitral Regurgitation on Eligibility for TAVI  

作　　者：Mattia Vinciguerra Mizar D’Abramo Beatrice Sciuccati Noemi Bruno Eleonora Wretschko Marco Totaro Antonio Barretta Fabio Miraldi Ernesto Greco 

机构地区：[1]Department of Clinical,Internal Medicine,Anesthesiology and Cardiovascular Sciences,Sapienza University of Rome,Rome,Italy 2Department of Health and Life Sciences,European University of Rome,Rome,Italy

出　　处：《Cardiovascular Innovations and Applications》2024年第1期669-671,共3页心血管创新与应用(英文)

摘　　要：Transcatheter aortic valve implantation(TAVI)has emerged as the primary treatment strategy for severe symptomatic aortic stenosis(AS)in the older population(>75 years of age)with high-risk surgical profiles[1].

关 键 词：older population degenerative mitral regurgitation prognostic implications aortic stenosis transcatheter aortic valve implantation 

分 类 号：R54[医药卫生—心血管疾病]